NOTCH1 and acute lymphoblastic leukemia: Multiple genetic abnormalities have been identified in T-ALL cases (13, 14), including proto-oncogene activation, tumor-suppressor gene deletions and constitutive activation of the NOTCH1 pathway, present in 40–60% of patients (15–17).